ArticleResearch square2026
Institutional Readiness and Diagnostic Challenges for the Management of Pyrexia of Unknown Origin (PUO) in Nepal: A Mixed-Methods Study at Tertiary Level Hospitals.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: Pyrexia of Unknown Origin (PUO) remains a significant diagnostic challenge in low-resource settings, where limited laboratory capacity and fragmented health systems impede timely etiologic identification. In Nepal, evidence on institutional readiness, diagnostic capacity, and system-level barriers for PUO care is limited, hindering standardized clinical decision-making and timely diagnosis. This study assessed the diagnostic capacity, workforce expertise, and governance structures for PUO management across Nepal. Methods: A concurrent mixed-methods study was conducted across 11 tertiary care hospitals in six provinces of Nepal. Quantitative data on governance, service delivery, diagnostics, human resources, infrastructure, and financing were collected using standardized facility assessment tools and descriptively analyzed using SPSS version 23. Qualitative data were obtained from 33 key informant semi-structured interviews (hospital administrators, clinicians, and laboratory personnel), transcribed verbatim, and subjected to thematic analysis in NVivo with intercoder reliability assessment. Findings were integrated through triangulation. Results: Quantitative assessments revealed limited institutional preparedness for PUO management, characterized by the absence of dedicated clinical guidelines, formal referral pathways, and designated focal points in most hospitals. Basic diagnostic services were widely available; however, access to advanced molecular diagnostics was inconsistent and often dependent on external laboratories, contributing to diagnostic delays. Qualitative findings contextualized these gaps, highlighting fragmented governance, weak interdisciplinary coordination, and heavy reliance on empirical treatment of pyrexia, frequently influenced by prior antibiotic exposure. Human resource constraints were prominent, particularly shortages of infectious disease specialists, pediatric expertise, microbiologists, and trained laboratory personnel. Infrastructure limitations, inefficient referral mechanisms, and substantial out-of-pocket expenditures further constrained optimal care. Digital health tools, including electronic medical records and telemedicine, were inconsistently implemented despite being viewed as potential facilitators of improved coordination and follow-up. Conclusions: Management of PUO in Nepal is limited by system-level weaknesses in governance, diagnostic capacity, workforce skills, financing, and digital health integration. Closing these gaps through standardized clinical guidelines, strengthened laboratory systems, focused workforce training, improved referral pathways, and strategic digital health investments could shorten diagnostic timelines, improve patient outcomes, and advance national priorities such as antimicrobial stewardship and epidemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.